Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoko Tabe

Showing results (11-20 of 166) with videos related to

Pageof 17
Sort By:
British Journal of Haematology|January 11, 2014
Advances in understanding the leukaemia microenvironmentYoko Tabe, Marina Konopleva
Blood|June 24, 2021
Break the lifeline of AML cellsYoko Tabe, Marina Konopleva
Cancer Drug Resistance (Alhambra, Calif.)|April 17, 2023
Resistance to energy metabolism - targeted therapy of AML cells residual in the bone marrow microenvironmentYoko Tabe, Marina Konopleva
Clinical Laboratory|May 10, 2016
Impact of Clotting Condition on the Measurement of Circulating MicroRNAs in SerumKazunari Hayashi, Yoko Tabe, Takashi Miida
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|November 11, 2006
[The anti-tumoral effect of PI3K inhibitor and MEK inhibitor combined with STI571 on chronic myeloid leukemia cells in a bone marrow stromal cell co-culture system]Linhua Jin, Atsushi Kato, Yoko Tabe
Frontiers in Oncology|March 6, 2020
Fatty Acid Metabolism, Bone Marrow Adipocytes, and AMLYoko Tabe, Marina Konopleva, Michael Andreeff
Blood|August 17, 2019
Amino acid metabolism in hematologic malignancies and the era of targeted therapyYoko Tabe, Philip L Lorenzi, Marina Konopleva
Acute Medicine & Surgery|June 23, 2018
Neutrophil extracellular traps, damage-associated molecular patterns, and cell death during sepsisToshiaki Iba, Miwa Murai, Isao Nagaoka, et al.
Rinsho Byori. the Japanese Journal of Clinical Pathology|October 14, 2004
Spontaneous migration of acute promyelocytic leukemia cells beneath cultured bone marrow adipocytes with matched expression of the major histocompatibility complexYoko Tabe, Marina Konopleva, Jun Igari, et al.
Biological & Pharmaceutical Bulletin|March 12, 2015
Comparative study of the anti-leukemic effects of imatinib mesylate, Glivec™ tablet and its generic formulation, OHK9511Masako Yokoo, Yasushi Kubota, Yoko Tabe, et al.
Pageof 17

Showing results (11-20 of 166) with videos related to

Sort By:
Pageof 17
British Journal of Haematology|January 11, 2014
Advances in understanding the leukaemia microenvironmentYoko Tabe, Marina Konopleva
Blood|June 24, 2021
Break the lifeline of AML cellsYoko Tabe, Marina Konopleva
Cancer Drug Resistance (Alhambra, Calif.)|April 17, 2023
Resistance to energy metabolism - targeted therapy of AML cells residual in the bone marrow microenvironmentYoko Tabe, Marina Konopleva
Clinical Laboratory|May 10, 2016
Impact of Clotting Condition on the Measurement of Circulating MicroRNAs in SerumKazunari Hayashi, Yoko Tabe, Takashi Miida
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|November 11, 2006
[The anti-tumoral effect of PI3K inhibitor and MEK inhibitor combined with STI571 on chronic myeloid leukemia cells in a bone marrow stromal cell co-culture system]Linhua Jin, Atsushi Kato, Yoko Tabe
Frontiers in Oncology|March 6, 2020
Fatty Acid Metabolism, Bone Marrow Adipocytes, and AMLYoko Tabe, Marina Konopleva, Michael Andreeff
Blood|August 17, 2019
Amino acid metabolism in hematologic malignancies and the era of targeted therapyYoko Tabe, Philip L Lorenzi, Marina Konopleva
Acute Medicine & Surgery|June 23, 2018
Neutrophil extracellular traps, damage-associated molecular patterns, and cell death during sepsisToshiaki Iba, Miwa Murai, Isao Nagaoka, et al.
Rinsho Byori. the Japanese Journal of Clinical Pathology|October 14, 2004
Spontaneous migration of acute promyelocytic leukemia cells beneath cultured bone marrow adipocytes with matched expression of the major histocompatibility complexYoko Tabe, Marina Konopleva, Jun Igari, et al.
Biological & Pharmaceutical Bulletin|March 12, 2015
Comparative study of the anti-leukemic effects of imatinib mesylate, Glivec™ tablet and its generic formulation, OHK9511Masako Yokoo, Yasushi Kubota, Yoko Tabe, et al.
Pageof 17